þ | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
o | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Delaware | 76-0336636 | |
(State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
|
13403 Northwest Freeway, Houston, Texas | 77040-6094 | |
(Address of principal executive offices) | (Zip Code) |
Page | ||||||||
Part I. FINANCIAL INFORMATION |
||||||||
Item 1. Financial Statements |
||||||||
5 | ||||||||
6 | ||||||||
7 | ||||||||
8 | ||||||||
9 | ||||||||
23 | ||||||||
33 | ||||||||
33 | ||||||||
34 | ||||||||
35 | ||||||||
35 | ||||||||
36 | ||||||||
36 | ||||||||
Certification by Chief Executive Officer | ||||||||
Certification by Chief Financial Officer | ||||||||
Certification with Respect to Quarterly Report |
2
| the effects of catastrophic losses; | ||
| the cyclical nature of the insurance business; | ||
| inherent uncertainties in the loss estimation process, which can adversely impact the adequacy of loss reserves; | ||
| the effects of emerging claim and coverage issues; | ||
| the effects of extensive governmental regulation of the insurance industry; | ||
| potential credit risk with brokers; | ||
| our assessment of underwriting risk; | ||
| our increased retention of risk, which could expose us to greater potential losses; | ||
| the adequacy of reinsurance protection; | ||
| the ability or willingness of reinsurers to pay balances due us; | ||
| the occurrence of terrorist activities; | ||
| our ability to maintain our competitive position; | ||
| changes in our assigned financial strength ratings; | ||
| our ability to raise capital in the future; | ||
| attraction and retention of qualified employees; | ||
| fluctuations in the fixed income securities market, which may reduce the value of our investment assets; | ||
| our ability to successfully expand our business through the acquisition of insurance-related companies; | ||
| our ability to receive dividends from our insurance company subsidiaries in needed amounts; | ||
| fluctuations in foreign exchange rates; | ||
| failures of our information technology systems; |
3
| impairment of goodwill; | ||
| developments in the SECs inquiry related to our past stock option granting procedures; | ||
| litigation related to our past stock option granting procedures; and | ||
| change of control. |
4
June 30, | December 31, | |||||||
2007 | 2006 | |||||||
ASSETS |
||||||||
Investments: |
||||||||
Fixed income securities, at fair value
(amortized cost: 2007 - $3,454,272; 2006 - $3,008,818) |
$ | 3,401,787 | $ | 3,007,193 | ||||
Short-term investments, at cost, which approximates fair value |
732,912 | 714,685 | ||||||
Other investments, at fair value (cost: 2007 - $175,187; 2006 - $183,450) |
214,812 | 206,117 | ||||||
Total investments |
4,349,511 | 3,927,995 | ||||||
Cash |
41,931 | 48,290 | ||||||
Restricted cash and cash investments |
171,215 | 176,424 | ||||||
Premium, claims and other receivables |
829,781 | 864,705 | ||||||
Reinsurance recoverables |
1,075,313 | 1,169,934 | ||||||
Ceded unearned premium |
247,374 | 226,125 | ||||||
Ceded life and annuity benefits |
68,038 | 70,923 | ||||||
Deferred policy acquisition costs |
197,375 | 182,410 | ||||||
Goodwill |
743,239 | 742,677 | ||||||
Other assets |
216,360 | 220,649 | ||||||
Total assets |
$ | 7,940,137 | $ | 7,630,132 | ||||
LIABILITIES |
||||||||
Loss and loss adjustment expense payable |
$ | 3,202,988 | $ | 3,097,051 | ||||
Life and annuity policy benefits |
68,038 | 70,923 | ||||||
Reinsurance balances payable |
121,932 | 122,805 | ||||||
Unearned premium |
983,232 | 920,350 | ||||||
Deferred ceding commissions |
71,496 | 64,949 | ||||||
Premium and claims payable |
598,915 | 646,224 | ||||||
Notes payable |
347,590 | 308,887 | ||||||
Accounts payable and accrued liabilities |
350,769 | 356,140 | ||||||
Total liabilities |
5,744,960 | 5,587,329 | ||||||
SHAREHOLDERS EQUITY |
||||||||
Common stock, $1.00 par value; 250.0 million shares authorized
(shares issued and outstanding: 2007 112,483; 2006 111,731) |
112,483 | 111,731 | ||||||
Additional paid-in capital |
820,272 | 798,213 | ||||||
Retained earnings |
1,273,614 | 1,098,887 | ||||||
Accumulated other comprehensive income (loss) |
(11,192 | ) | 33,972 | |||||
Total shareholders equity |
2,195,177 | 2,042,803 | ||||||
Total liabilities and shareholders equity |
$ | 7,940,137 | $ | 7,630,132 | ||||
5
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
REVENUE |
||||||||||||||||
Net earned premium |
$ | 991,986 | $ | 783,891 | $ | 494,386 | $ | 403,320 | ||||||||
Fee and commission income |
63,261 | 65,547 | 31,136 | 33,878 | ||||||||||||
Net investment income |
98,164 | 72,754 | 48,697 | 36,173 | ||||||||||||
Net realized investment loss |
(624 | ) | (1,497 | ) | (69 | ) | (199 | ) | ||||||||
Other operating income |
38,685 | 38,795 | 20,100 | 20,045 | ||||||||||||
Total revenue |
1,191,472 | 959,490 | 594,250 | 493,217 | ||||||||||||
EXPENSE |
||||||||||||||||
Loss and loss adjustment expense, net |
603,763 | 453,092 | 303,291 | 231,025 | ||||||||||||
Policy acquisition costs, net |
174,527 | 152,809 | 85,428 | 76,577 | ||||||||||||
Other operating expense |
111,108 | 97,002 | 53,467 | 49,669 | ||||||||||||
Interest expense |
4,399 | 4,437 | 1,096 | 2,283 | ||||||||||||
Total expense |
893,797 | 707,340 | 443,282 | 359,554 | ||||||||||||
Earnings before income tax expense |
297,675 | 252,150 | 150,968 | 133,663 | ||||||||||||
Income tax expense |
99,813 | 83,864 | 49,796 | 44,519 | ||||||||||||
Net earnings |
$ | 197,862 | $ | 168,286 | $ | 101,172 | $ | 89,144 | ||||||||
Basic earnings per share data: |
||||||||||||||||
Net earnings per share |
$ | 1.76 | $ | 1.51 | $ | 0.90 | $ | 0.80 | ||||||||
Weighted average shares outstanding |
112,117 | 111,117 | 112,273 | 111,218 | ||||||||||||
Diluted earnings per share data: |
||||||||||||||||
Net earnings per share |
$ | 1.69 | $ | 1.44 | $ | 0.86 | $ | 0.76 | ||||||||
Weighted average shares outstanding |
117,381 | 116,885 | 117,728 | 116,860 | ||||||||||||
Cash dividends declared, per share |
$ | 0.20 | $ | 0.175 | $ | 0.10 | $ | 0.10 | ||||||||
6
Accumulated | ||||||||||||||||||||
Additional | other | Total | ||||||||||||||||||
Common | paid-in | Retained | comprehensive | shareholders | ||||||||||||||||
stock | capital | earnings | income (loss) | equity | ||||||||||||||||
Balance at December 31, 2006 |
$ | 111,731 | $ | 798,213 | $ | 1,098,887 | $ | 33,972 | $ | 2,042,803 | ||||||||||
Cumulative effect of accounting change
(adoption of FIN 48) |
| | (678 | ) | | (678 | ) | |||||||||||||
Net earnings |
| | 197,862 | | 197,862 | |||||||||||||||
Other comprehensive loss |
| | | (45,164 | ) | (45,164 | ) | |||||||||||||
Comprehensive income |
152,020 | |||||||||||||||||||
Issuance of 730 shares for exercise of
options, including tax benefit of $2,517 |
730 | 15,692 | | | 16,422 | |||||||||||||||
Issuance of 22 shares to directors |
22 | 695 | | | 717 | |||||||||||||||
Stock-based compensation |
| 5,672 | | | 5,672 | |||||||||||||||
Cash dividends declared, $0.20 per share |
| | (22,457 | ) | | (22,457 | ) | |||||||||||||
Balance at June 30, 2007 |
$ | 112,483 | $ | 820,272 | $ | 1,273,614 | $ | (11,192 | ) | $ | 2,195,177 | |||||||||
7
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
Cash flows from operating activities: |
||||||||||||||||
Net earnings |
$ | 197,862 | $ | 168,286 | $ | 101,172 | $ | 89,144 | ||||||||
Adjustments to reconcile net earnings to
net cash provided by operating activities: |
||||||||||||||||
Change in premium, claims and other
receivables |
30,041 | (10,298 | ) | (57,125 | ) | (54,660 | ) | |||||||||
Change in reinsurance recoverables |
94,621 | 8,695 | (16,646 | ) | (3,937 | ) | ||||||||||
Change in ceded unearned premium |
(21,249 | ) | 1,135 | (23,139 | ) | 1,249 | ||||||||||
Change in loss and loss adjustment
expense payable |
105,937 | 104,721 | 89,492 | 80,946 | ||||||||||||
Change in reinsurance balances payable |
(873 | ) | (22,706 | ) | 7,452 | 4,351 | ||||||||||
Change in unearned premium |
62,882 | 103,079 | 65,504 | 84,813 | ||||||||||||
Change in premium and claims payable,
net of restricted cash |
(42,100 | ) | (17,222 | ) | 44,587 | 13,096 | ||||||||||
Change in trading portfolio |
4,865 | (84,491 | ) | (6,093 | ) | (36,497 | ) | |||||||||
Depreciation and amortization expense |
7,861 | 7,644 | 4,125 | 3,819 | ||||||||||||
Stock-based compensation expense |
6,389 | 6,090 | 4,178 | 3,387 | ||||||||||||
Other, net |
(45,936 | ) | (4,992 | ) | (43,518 | ) | (3,861 | ) | ||||||||
Cash provided by operating activities |
400,300 | 259,941 | 169,989 | 181,850 | ||||||||||||
Cash flows from investing activities: |
||||||||||||||||
Sales of fixed income securities |
174,718 | 164,097 | 146,235 | 98,443 | ||||||||||||
Maturity or call of fixed income securities |
158,121 | 117,698 | 87,973 | 58,472 | ||||||||||||
Cost of securities acquired |
(736,873 | ) | (791,385 | ) | (369,678 | ) | (319,771 | ) | ||||||||
Change in short-term investments |
(26,014 | ) | 218,856 | (50,871 | ) | (27,894 | ) | |||||||||
Sale of strategic investment |
39,816 | 17,363 | 16,866 | | ||||||||||||
Payments for purchase of subsidiaries, net
of cash received |
(51,681 | ) | (37,457 | ) | (45,764 | ) | (13,457 | ) | ||||||||
Other, net |
(5,356 | ) | (5,097 | ) | (3,188 | ) | (3,050 | ) | ||||||||
Cash used by
investing activities |
(447,269 | ) | (315,925 | ) | (218,427 | ) | (207,257 | ) | ||||||||
Cash flows from financing activities: |
||||||||||||||||
Advances on line of credit |
62,000 | 39,000 | 51,000 | 28,000 | ||||||||||||
Payments on notes payable and line of credit |
(12,887 | ) | (11,249 | ) | (1,548 | ) | (142 | ) | ||||||||
Sale of common stock |
16,422 | 9,660 | 8,382 | 2,022 | ||||||||||||
Dividends paid |
(22,381 | ) | (16,648 | ) | (11,208 | ) | (8,338 | ) | ||||||||
Other |
(2,544 | ) | 5,628 | 1,251 | (2,904 | ) | ||||||||||
Cash provided by financing
activities |
40,610 | 26,391 | 47,877 | 18,638 | ||||||||||||
Net decrease in cash |
(6,359 | ) | (29,593 | ) | (561 | ) | (6,769 | ) | ||||||||
Cash at beginning of period |
48,290 | 73,935 | 42,492 | 51,111 | ||||||||||||
Cash at end of period |
$ | 41,931 | $ | 44,342 | $ | 41,931 | $ | 44,342 | ||||||||
8
(1) | GENERAL INFORMATION | |
HCC Insurance Holdings, Inc. and its subsidiaries (collectively, we, us or our) include domestic and foreign property and casualty and life insurance companies, underwriting agencies and reinsurance brokers. We provide specialized property and casualty, surety, and group life, accident and health insurance coverages and related agency and reinsurance brokerage services to commercial customers and individuals. We market our products both directly to customers and through a network of independent and affiliated brokers, producers and agents. Our lines of business include diversified financial products (which includes directors and officers liability, professional indemnity, employment practices liability, surety and credit); group life, accident and health; aviation; our London market account (which includes energy, marine, property, and accident and health); and other specialty lines of insurance. We operate primarily in the United States, the United Kingdom, Spain, Bermuda and Ireland, although some of our operations have a broader international scope. | ||
Basis of Presentation | ||
Our unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (generally accepted accounting principles) and include the accounts of HCC Insurance Holdings, Inc. and its subsidiaries. We have made all adjustments that, in our opinion, are necessary for a fair presentation of results of the interim periods, and all such adjustments are of a normal recurring nature. All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated financial statements should be read in conjunction with our annual audited consolidated financial statements and related notes. The condensed consolidated balance sheet at December 31, 2006 was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles. | ||
Management must make estimates and assumptions that affect amounts reported in our condensed consolidated financial statements and in disclosures of contingent assets and liabilities. Ultimate results could differ from those estimates. | ||
We completed an acquisition as of June 30, 2006 and two more in the second half of 2006. Our condensed consolidated statements of earnings and cash flows for the six months and three months ended June 30, 2006 do not contain any operations of the acquired entities. | ||
Acquisition | ||
On October 2, 2006, we acquired the Health Products Division of Allianz Life Insurance Company of North America (the Health Products Division) in a purchase business combination for $140.0 million. In addition, we assumed the Health Products Divisions outstanding loss reserves totaling $149.7 million and net miscellaneous other liabilities of $0.4 million. Allianz paid us the net amount of $10.1 million in cash. We acquired the Health Products Division to expand our medical stop-loss line and diversify our business by adding several new medical excess products; to add skilled underwriters and managers with extensive experience with medical stop-loss and medical excess products; to apply our unique synergies to the Health Products Divisions business to increase its profitability; and to strengthen our competitive position as a leader in the medical stop-loss and excess lines. | ||
We expect the Health Products Division to generate a profit and positive cash flow due to the unique synergies (specialized systems, claims administration, operational focus and management expertise) our existing medical stop-loss business will contribute to the combined, post-acquisition business. For our purchase price allocation, |
9
we assessed the value of these synergies, as well as the value of the assembled workforce. The value of these items was subsumed into goodwill in accordance with Statement of Financial Accounting Standards (SFAS) No. 141, Business Combinations. We valued all identifiable assets and liabilities at fair value, including discounting the loss reserves by $2.9 million. The following table summarizes the fair value of assets acquired and liabilities assumed and the resulting $137.2 million of goodwill: |
Premium, claims and other receivables |
$ | 6,372 | ||
Goodwill |
137,154 | |||
Other assets |
280 | |||
Total assets acquired |
143,806 | |||
Loss and loss adjustment expense payable |
146,811 | |||
Reinsurance balances payable |
746 | |||
Premium and claims payable |
4,375 | |||
Accounts payable and accrued liabilities |
1,961 | |||
Total liabilities assumed |
153,893 | |||
Net cash received |
$ | 10,087 | ||
Income Tax | ||
For the six months ended June 30, 2007 and 2006, the income tax provision was calculated based on an estimated effective tax rate for each fiscal year. Our effective tax rate differs from the United States Federal statutory rate primarily due to tax-exempt municipal bond interest and state income taxes. | ||
Stock-Based Compensation | ||
During the second quarter of 2007, fully-vested common stock valued at $80,000 was granted to each non-management director as part of their annual compensation for serving on our Board of Directors. The number of shares granted to each director was based on the closing price on the grant date, which was either the day of the Annual Meeting of Shareholders or the day the director joined the Board, if later. The shares granted had an aggregate fair value of $0.7 million, which we recognized as compensation expense on the grant date. | ||
In the second quarter of 2007, we granted options for the purchase of 475,000 shares of our common stock at $31.92 per share. In the first quarter of 2007, we granted options for the purchase of 2,050,750 shares of our common stock at $31.11 per share. The aggregate fair value of options granted in 2007 was $16.9 million, which will be expensed over a vesting period of three to five years. |
We incurred $3.6 million of expense in 2007 for professional services, consulting fees and other related charges for ongoing issues associated with our 2006 stock option matter, which is described in more detail in Note 7 Commitments and Contingencies. In order to maintain our excellent employee relations and treat our employees fairly, our Board of Directors decided to incur certain costs and reimburse employees for certain expenses related to our 2006 stock option matter. During the first quarter, we paid the personal tax liabilities that our employees incurred under Section 409A of the Internal Revenue Code for options exercised in 2006, thus resolving the $2.3 million liability accrued at December 31, 2006. We commenced a Tender Offer on July 9, 2007 relating to our plan to reprice certain employees unexercised discounted options and provide cash reimbursements for the increase in option price. The tender offer expired on August 7, 2007, and all employees accepted our offer to reprice their options. We will make the initial cash reimbursements on January 15, 2008. The estimated cost of $4.0 million for the aggregate reimbursements was accrued at December 31, 2006. During the first quarter of 2007, we collected $6.1 million of receivables due from certain former executives related to the 2006 stock option matter. |
10
Recent Accounting Changes | ||
FIN 48 | ||
FIN No. 48, Accounting for Uncertainty in Income Taxes, issued by the Financial Accounting Standards Board (FASB) in 2006, became effective January 1, 2007. FIN 48 clarifies the accounting for uncertain income tax positions. Under FIN 48, a company may only recognize the tax benefit from an uncertain tax position if it is more-likely-than-not the tax position will be sustained upon examination by the tax authority. To adopt FIN 48, a company must recognize a tax liability related to the uncertain tax positions, to the extent the liability is not already recorded. The cumulative effect of the accounting change is reflected as a reduction of beginning retained earnings on the date of adoption. | ||
On January 1, 2007, the date we adopted FIN 48, our gross tax benefits related to uncertain tax positions totaled $9.9 million and related potential interest totaled $1.4 million, for which we had previously recorded $9.2 million of gross tax liabilities on unrecognized tax benefits. To adopt FIN 48 and record the additional required tax and interest liabilities, we reduced beginning retained earnings by $0.7 million, primarily for potential interest net of the related Federal tax benefit. Subsequent to adoption, we will report any potential interest and penalties in interest expense and other operating expense, respectively, in our consolidated statement of earnings, consistent with our prior classification of such expenses. In addition, changes in the recognition or amount of our uncertain tax positions generally will be reflected as a component of income tax expense. | ||
Of the total amount of our tax benefits related to uncertain tax positions, $9.1 million would positively affect the effective tax rate if the uncertain tax benefits were recognized as a reduction of income tax expense currently. As of the date of adoption, it was reasonably possible that the liabilities for our unrecognized tax benefits could decrease by $1.4 million in the subsequent twelve months, mainly due to the expiration of the statute of limitations related to state tax liabilities. As of June 30, 2007, it is reasonably possible that the liabilities for our unrecognized tax benefits could decrease by an additional $1.1 million in the next twelve months, mainly due to the settlement of ongoing audits with foreign tax authorities. We are subject to examination by the Internal Revenue Service and most state tax jurisdictions for the years 2003 and forward and by major foreign tax jurisdictions for the years 2001 and forward. | ||
SFAS 157 and 159 | ||
The FASB has issued SFAS No. 157, Fair Value Measurements, which clarifies the definition of fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurement. SFAS 157 does not require any new fair value measurements and eliminates inconsistencies in guidance found in various prior accounting pronouncements. The FASB has also issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities. SFAS 159 permits a company to choose to measure eligible financial assets and liabilities at fair value that are not currently required to be measured at fair value. Unrealized gains and losses for those items are reported in current earnings at each subsequent reporting date. Both SFAS 157 and SFAS 159 will be effective on January 1, 2008. We are currently assessing what impact SFAS 157 will have on our consolidated financial statements and whether we will adopt SFAS 159. |
11
(2) | REINSURANCE | |
In the normal course of business, our insurance companies cede a portion of their premium to domestic and foreign reinsurers through treaty and facultative reinsurance agreements. Although ceding for reinsurance purposes does not discharge the primary insurer from liability to its policyholder, our insurance companies participate in such agreements in order to limit their loss exposure, protect them against catastrophic loss and diversify their business. The following table presents the effect of such reinsurance transactions on our premium and loss and loss adjustment expense. |
Loss and loss | ||||||||||||
Written | Earned | adjustment | ||||||||||
premium | premium | expense | ||||||||||
Six months ended June 30, 2007 |
||||||||||||
Primary business |
$ | 1,011,630 | $ | 978,161 | $ | 570,661 | ||||||
Reinsurance assumed |
253,072 | 227,101 | 152,399 | |||||||||
Reinsurance ceded |
(233,917 | ) | (213,276 | ) | (119,297 | ) | ||||||
Net amounts |
$ | 1,030,785 | $ | 991,986 | $ | 603,763 | ||||||
Six months ended June 30, 2006 |
||||||||||||
Primary business |
$ | 932,332 | $ | 866,566 | $ | 476,183 | ||||||
Reinsurance assumed |
159,780 | 135,596 | 83,123 | |||||||||
Reinsurance ceded |
(215,579 | ) | (218,271 | ) | (106,214 | ) | ||||||
Net amounts |
$ | 876,533 | $ | 783,891 | $ | 453,092 | ||||||
Three months ended June 30, 2007 |
||||||||||||
Primary business |
$ | 553,128 | $ | 492,791 | $ | 283,210 | ||||||
Reinsurance assumed |
112,473 | 110,628 | 89,402 | |||||||||
Reinsurance ceded |
(131,781 | ) | (109,033 | ) | (69,321 | ) | ||||||
Net amounts |
$ | 533,820 | $ | 494,386 | $ | 303,291 | ||||||
Three months ended June 30, 2006 |
||||||||||||
Primary business |
$ | 522,141 | $ | 444,056 | $ | 248,933 | ||||||
Reinsurance assumed |
63,913 | 64,716 | 37,332 | |||||||||
Reinsurance ceded |
(102,572 | ) | (105,452 | ) | (55,240 | ) | ||||||
Net amounts |
$ | 483,482 | $ | 403,320 | $ | 231,025 | ||||||
Ceding commissions netted with policy acquisition costs in the condensed consolidated statements of earnings were $21.8 million in the first six months of 2007 and $22.5 million in the first six months of 2006. |
12
The table below shows the components of reinsurance recoverables in our condensed consolidated balance sheets. |
June 30, | December 31, | |||||||
2007 | 2006 | |||||||
Commutation receivable |
$ | | $ | 100,000 | ||||
Reinsurance recoverable on paid losses |
109,567 | 96,727 | ||||||
Reinsurance recoverable on outstanding losses |
502,963 | 529,562 | ||||||
Reinsurance recoverable on incurred but not reported losses |
473,209 | 458,528 | ||||||
Reserve for uncollectible reinsurance |
(10,426 | ) | (14,883 | ) | ||||
Total reinsurance recoverables |
$ | 1,075,313 | $ | 1,169,934 | ||||
Our reserve for uncollectible reinsurance covers potential collectibility issues, including disputed amounts and associated expenses. While we believe the reserve is adequate based on information currently available, conditions may change or additional information might be obtained that may require us to change the reserve in the future. We periodically review our financial exposure to the reinsurance market and the level of our reserve and continue to take actions in an attempt to mitigate our exposure to possible loss. | ||
We limit the liquidity exposure related to our reinsurance recoverables by holding funds, letters of credit or other security, with the result that net balances due are significantly less than the gross balances shown in our condensed consolidated balance sheets. Additionally, our U.S. domiciled insurance companies require certain reinsurers (those not authorized by the insurance companys state of domicile) to collateralize their reinsurance obligations due to us. The table below shows the amounts of letters of credit and cash deposits held by us as collateral, plus other credits available for potential offset. |
June 30, | December 31, | |||||||
2007 | 2006 | |||||||
Payables to reinsurers |
$ | 297,025 | $ | 268,079 | ||||
Letters of credit |
255,806 | 326,204 | ||||||
Cash deposits |
59,345 | 61,002 | ||||||
Total credits |
$ | 612,176 | $ | 655,285 | ||||
13
The tables below present the calculation of net reserves, net unearned premium and net deferred policy acquisition costs. |
June 30, | December 31, | |||||||
2007 | 2006 | |||||||
Loss and loss adjustment expense payable |
$ | 3,202,988 | $ | 3,097,051 | ||||
Reinsurance recoverable on outstanding losses |
(502,963 | ) | (529,562 | ) | ||||
Reinsurance recoverable on incurred but not reported losses |
(473,209 | ) | (458,528 | ) | ||||
Net reserves |
$ | 2,226,816 | $ | 2,108,961 | ||||
Unearned premium |
$ | 983,232 | $ | 920,350 | ||||
Ceded unearned premium |
(247,374 | ) | (226,125 | ) | ||||
Net unearned premium |
$ | 735,858 | $ | 694,225 | ||||
Deferred policy acquisition costs |
$ | 197,375 | $ | 182,410 | ||||
Deferred ceding commissions |
(71,496 | ) | (64,949 | ) | ||||
Net deferred policy acquisition costs |
$ | 125,879 | $ | 117,461 | ||||
(3) | NOTES PAYABLE | |
The following table shows the detail of notes payable. |
June 30, | December 31, | |||||||
2007 | 2006 | |||||||
1.30% Convertible Notes |
$ | 124,723 | $ | 124,977 | ||||
2.00% Convertible Exchange Notes |
171,867 | 172,174 | ||||||
$300.0 million Revolving Loan Facility |
51,000 | | ||||||
Other |
| 11,736 | ||||||
Total notes payable |
$ | 347,590 | $ | 308,887 | ||||
Our 1.30% Convertible Notes are due in 2023. We pay interest semi-annually on April 1 and October 1. Each one thousand dollar principal amount of notes is convertible into 44.1501 shares of our common stock, which represents an initial conversion price of $22.65 per share. The initial conversion price is subject to standard anti-dilution provisions designed to maintain the value of the conversion option in the event we take certain actions with respect to our common stock, such as stock splits, reverse stock splits, stock dividends and extraordinary dividends, that affect all of the holders of our common stock equally and that could have a dilutive effect on the value of the conversion rights of the holders of the notes or that confer a benefit upon our current stockholders not otherwise available to the Convertible Notes. Holders may surrender notes for conversion if, as of the last day of the preceding calendar quarter, the closing sale price of our common stock for at least 20 consecutive trading days during the period of 30 consecutive trading days ending on the last trading day of that quarter is more than 130% ($29.45 per share) of the conversion price per share of our common stock. We must settle any conversions by paying cash for the principal amount of the notes and issuing our common stock for the value of the conversion premium. We can redeem the notes for cash at any time on or after April 1, 2009. Holders may require us to repurchase the notes on April 1, 2009, 2014 or 2019, or if a change in control of HCC Insurance Holdings, Inc. |
14
occurs on or before April 1, 2009. The repurchase price to settle any such put or change in control provisions will equal the principal amount of the notes plus accrued and unpaid interest and will be paid in cash. | ||
Our 2.00% Convertible Exchange Notes are due in 2021. We pay interest semi-annually on March 1 and September 1. Each one thousand dollar principal amount is convertible into 46.8823 shares of our common stock, which represents an initial conversion price of $21.33 per share. The initial conversion price is subject to standard anti-dilution provisions designed to maintain the value of the conversion option in the event we take certain actions with respect to our common stock, such as stock splits, reverse stock splits, stock dividends and extraordinary dividends, that affect all of the holders of our common stock equally and that could have a dilutive effect on the value of the conversion rights of the holders of the notes or that confer a benefit upon our current stockholders not otherwise available to the Convertible Exchange Notes. Holders may surrender notes for conversion if, as of the last day of the preceding calendar quarter, the closing sale price of our common stock for at least 20 trading days in the period of 30 consecutive trading days ending on the last trading day of that quarter is more than 120% ($25.60 per share) of the conversion price per share of our common stock. We must settle any conversion by paying cash for the principal amount of the notes and issuing our common stock for the value of the conversion premium. We can redeem the notes for cash at any time on or after September 1, 2007. Holders may require us to repurchase the notes on September 1, 2007, 2011 or 2016, or if a change in control of HCC Insurance Holdings, Inc. occurs on or before September 1, 2007. The repurchase price to settle any such put or change in control provisions will equal the principal amount of the notes plus accrued and unpaid interest and will be paid in cash. | ||
In April 2007, we replaced our $300.0 million Revolving Loan Facility with a similar facility, which allows us to borrow up to the maximum allowed by the facility on a revolving basis until the facility expires on December 19, 2011. The new facility has more favorable terms than our prior facility. At our option, subject to the lenders ability to obtain the necessary commitments, the amount available under the facility may be increased to an aggregate of $700.0 million. | ||
(4) | EARNINGS PER SHARE | |
The following table details the numerator and denominator used in the earnings per share calculations. |
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
Net earnings |
$ | 197,862 | $ | 168,286 | $ | 101,172 | $ | 89,144 | ||||||||
Weighted average common shares
outstanding |
112,117 | 111,117 | 112,273 | 111,218 | ||||||||||||
Dilutive effect of outstanding options
(determined using the treasury stock
method) |
1,045 | 1,492 | 1,069 | 1,442 | ||||||||||||
Dilutive effect of convertible debt
(determined using the treasury stock
method) |
4,219 | 4,276 | 4,386 | 4,200 | ||||||||||||
Weighted average common shares and
potential common shares outstanding |
117,381 | 116,885 | 117,728 | 116,860 | ||||||||||||
Anti-dilutive stock options not included in
treasury stock method computation |
2,482 | 2,733 | 3,268 | 2,914 | ||||||||||||
15
(5) | SEGMENT AND GEOGRAPHIC INFORMATION | |
The performance of each segment is evaluated by our management based on net earnings. Net earnings is calculated after tax and after corporate expense allocations, interest expense on debt incurred at the purchase date, and intercompany eliminations have been charged or credited to our individual segments. All stock-based compensation is included in the corporate segment since it is not included in managements evaluation of the other segments. The following tables show information by business segment and geographic location. Geographic location is determined by physical location of our offices and does not represent the location of insureds or reinsureds from whom the business was generated. Effective April 1, 2006, we consolidated our London underwriting agency (agency segment) into HCC International Insurance Company (insurance company segment). |
Insurance | Other | |||||||||||||||||||
Company | Agency | Operations | Corporate | Total | ||||||||||||||||
Six months ended June 30, 2007 |
||||||||||||||||||||
Revenue: |
||||||||||||||||||||
Domestic |
$ | 916,844 | $ | 29,999 | $ | 38,226 | $ | 997 | $ | 986,066 | ||||||||||
Foreign |
186,850 | 18,556 | | | 205,406 | |||||||||||||||
Inter-segment |
| 37,650 | | | 37,650 | |||||||||||||||
Total segment revenue |
$ | 1,103,694 | $ | 86,205 | $ | 38,226 | $ | 997 | 1,229,122 | |||||||||||
Inter-segment eliminations |
(37,650 | ) | ||||||||||||||||||
Consolidated total revenue |
$ | 1,191,472 | ||||||||||||||||||
Net earnings (loss): |
||||||||||||||||||||
Domestic |
$ | 132,349 | $ | 12,162 | $ | 24,177 | $ | (9,566 | ) | $ | 159,122 | |||||||||
Foreign |
36,037 | 2,108 | | | 38,145 | |||||||||||||||
Total segment net earnings
(loss) |
$ | 168,386 | $ | 14,270 | $ | 24,177 | $ | (9,566 | ) | 197,267 | ||||||||||
Inter-segment eliminations |
595 | |||||||||||||||||||
Consolidated net earnings |
$ | 197,862 | ||||||||||||||||||
Other items: |
||||||||||||||||||||
Net investment income |
$ | 90,794 | $ | 4,721 | $ | 2,010 | $ | 639 | $ | 98,164 | ||||||||||
Depreciation and amortization |
2,353 | 3,945 | 148 | 1,415 | 7,861 | |||||||||||||||
Interest expense (benefit) |
836 | 5,894 | 5 | (2,336 | ) | 4,399 | ||||||||||||||
Capital expenditures |
2,457 | 987 | 316 | 1,596 | 5,356 | |||||||||||||||
Income tax expense (benefit) |
$ | 79,965 | $ | 12,110 | $ | 12,824 | $ | (5,733 | ) | $ | 99,166 | |||||||||
Inter-segment eliminations |
647 | |||||||||||||||||||
Consolidated income tax expense |
$ | 99,813 | ||||||||||||||||||
16
Insurance | Other | |||||||||||||||||||
Company | Agency | Operations | Corporate | Total | ||||||||||||||||
Six months ended June 30, 2006 |
||||||||||||||||||||
Revenue: |
||||||||||||||||||||
Domestic |
$ | 703,602 | $ | 29,675 | $ | 38,894 | $ | 2,514 | $ | 774,685 | ||||||||||
Foreign |
164,999 | 19,806 | | | 184,805 | |||||||||||||||
Inter-segment |
13 | 37,169 | | | 37,182 | |||||||||||||||
Total segment revenue |
$ | 868,614 | $ | 86,650 | $ | 38,894 | $ | 2,514 | 996,672 | |||||||||||
Inter-segment eliminations |
(37,182 | ) | ||||||||||||||||||
Consolidated total revenue |
$ | 959,490 | ||||||||||||||||||
Net earnings (loss): |
||||||||||||||||||||
Domestic |
$ | 104,695 | $ | 13,373 | $ | 25,115 | $ | (6,044 | ) | $ | 137,139 | |||||||||
Foreign |
24,798 | 6,244 | | | 31,042 | |||||||||||||||
Total segment net earnings
(loss) |
$ | 129,493 | $ | 19,617 | $ | 25,115 | $ | (6,044 | ) | 168,181 | ||||||||||
Inter-segment eliminations |
105 | |||||||||||||||||||
Consolidated net earnings |
$ | 168,286 | ||||||||||||||||||
Other items: |
||||||||||||||||||||
Net investment income |
$ | 65,381 | $ | 4,576 | $ | 1,878 | $ | 919 | $ | 72,754 | ||||||||||
Depreciation and amortization |
2,271 | 4,037 | 254 | 1,082 | 7,644 | |||||||||||||||
Interest expense (benefit) |
720 | 5,868 | 264 | (2,415 | ) | 4,437 | ||||||||||||||
Capital expenditures |
1,179 | 1,189 | 495 | 3,267 | 6,130 | |||||||||||||||
Income tax expense (benefit) |
$ | 60,457 | $ | 14,077 | $ | 12,459 | $ | (3,291 | ) | $ | 83,702 | |||||||||
Inter-segment eliminations |
162 | |||||||||||||||||||
Consolidated income tax expense |
$ | 83,864 | ||||||||||||||||||
17
Insurance | Other | |||||||||||||||||||
Company | Agency | Operations | Corporate | Total | ||||||||||||||||
Three months ended June 30, 2007 |
||||||||||||||||||||
Revenue: |
||||||||||||||||||||
Domestic |
$ | 458,084 | $ | 15,042 | $ | 19,950 | $ | 600 | $ | 493,676 | ||||||||||
Foreign |
92,041 | 8,533 | | | 100,574 | |||||||||||||||
Inter-segment |
| 23,664 | | | 23,664 | |||||||||||||||
Total segment revenue |
$ | 550,125 | $ | 47,239 | $ | 19,950 | $ | 600 | 617,914 | |||||||||||
Inter-segment eliminations |
(23,664 | ) | ||||||||||||||||||
Consolidated total revenue |
$ | 594,250 | ||||||||||||||||||
Net earnings (loss): |
||||||||||||||||||||
Domestic |
$ | 65,554 | $ | 7,458 | $ | 12,798 | $ | (3,481 | ) | $ | 82,329 | |||||||||
Foreign |
18,656 | 1,887 | | | 20,543 | |||||||||||||||
Total segment net earnings
(loss) |
$ | 84,210 | $ | 9,345 | $ | 12,798 | $ | (3,481 | ) | 102,872 | ||||||||||
Inter-segment eliminations |
(1,700 | ) | ||||||||||||||||||
Consolidated net earnings |
$ | 101,172 | ||||||||||||||||||
Other items: |
||||||||||||||||||||
Net investment income |
$ | 45,029 | $ | 2,283 | $ | 1,023 | $ | 362 | $ | 48,697 | ||||||||||
Depreciation and amortization |
1,174 | 2,199 | 36 | 716 | 4,125 | |||||||||||||||
Interest expense (benefits) |
372 | 3,129 | (25 | ) | (2,380 | ) | 1,096 | |||||||||||||
Capital expenditures |
1,429 | 333 | 316 | 1,110 | 3,188 | |||||||||||||||
Income tax expense (benefit) |
$ | 39,884 | $ | 7,638 | $ | 6,334 | $ | (3,196 | ) | $ | 50,660 | |||||||||
Inter-segment eliminations |
(864 | ) | ||||||||||||||||||
Consolidated income tax expense |
$ | 49,796 | ||||||||||||||||||
18
Insurance | Other | |||||||||||||||||||
Company | Agency | Operations | Corporate | Total | ||||||||||||||||
Three months ended June 30, 2006 |
||||||||||||||||||||
Revenue: |
||||||||||||||||||||
Domestic |
$ | 359,914 | $ | 14,906 | $ | 19,113 | $ | 1,337 | $ | 395,270 | ||||||||||
Foreign |
88,150 | 9,797 | | | 97,947 | |||||||||||||||
Inter-segment |
7 | 19,211 | | | 19,218 | |||||||||||||||
Total segment revenue |
$ | 448,071 | $ | 43,914 | $ | 19,113 | $ | 1,337 | 512,435 | |||||||||||
Inter-segment eliminations |
(19,218 | ) | ||||||||||||||||||
Consolidated total revenue |
$ | 493,217 | ||||||||||||||||||
Net earnings (loss): |
||||||||||||||||||||
Domestic |
$ | 54,726 | $ | 8,138 | $ | 12,126 | $ | (2,930 | ) | $ | 72,060 | |||||||||
Foreign |
14,710 | 2,555 | | | 17,265 | |||||||||||||||
Total segment net earnings
(loss) |
$ | 69,436 | $ | 10,693 | $ | 12,126 | $ | (2,930 | ) | 89,325 | ||||||||||
Inter-segment eliminations |
(181 | ) | ||||||||||||||||||
Consolidated net earnings |
$ | 89,144 | ||||||||||||||||||
Other items: |
||||||||||||||||||||
Net investment income |
$ | 33,374 | $ | 2,280 | $ | 243 | $ | 276 | $ | 36,173 | ||||||||||
Depreciation and amortization |
1,133 | 2,024 | 127 | 535 | 3,819 | |||||||||||||||
Interest expense (benefit) |
345 | 3,022 | 150 | (1,234 | ) | 2,283 | ||||||||||||||
Capital expenditures |
718 | 374 | 57 | 1,901 | 3,050 | |||||||||||||||
Income tax expense (benefit) |
$ | 32,361 | $ | 7,409 | $ | 6,318 | $ | (1,433 | ) | $ | 44,655 | |||||||||
Inter-segment eliminations |
(136 | ) | ||||||||||||||||||
Consolidated income tax expense |
$ | 44,519 | ||||||||||||||||||
19
The following tables present selected revenue items by line of business. |
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
Diversified financial products |
$ | 385,851 | $ | 348,319 | $ | 193,337 | $ | 179,207 | ||||||||
Group life, accident and health |
384,640 | 256,023 | 192,224 | 128,262 | ||||||||||||
Aviation |
77,091 | 72,231 | 37,747 | 39,034 | ||||||||||||
London market account |
64,499 | 48,865 | 30,603 | 26,937 | ||||||||||||
Other specialty lines |
80,335 | 58,536 | 40,597 | 29,896 | ||||||||||||
Discontinued lines |
(430 | ) | (83 | ) | (122 | ) | (16 | ) | ||||||||
Net earned premium |
$ | 991,986 | $ | 783,891 | $ | 494,386 | $ | 403,320 | ||||||||
Property and casualty |
$ | 53,960 | $ | 53,451 | $ | 26,485 | $ | 28,044 | ||||||||
Accident and health |
9,301 | 12,096 | 4,651 | 5,834 | ||||||||||||
Fee and commission income |
$ | 63,261 | $ | 65,547 | $ | 31,136 | $ | 33,878 | ||||||||
(6) | SUPPLEMENTAL INFORMATION | |
Supplemental cash flow information was as follows. |
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
Cash received from commutations |
$ | 101,040 | $ | | $ | | $ | | ||||||||
Income taxes paid |
82,492 | 74,874 | 72,107 | 58,836 | ||||||||||||
Interest paid |
3,596 | 3,488 | 278 | 553 | ||||||||||||
Comprehensive income |
152,020 | 143,218 | 60,722 | 80,596 |
(7) | COMMITMENTS AND CONTINGENCIES |
In 2006, based on a voluntary independent investigation by a Special Committee of the Board of Directors of our past practices related to granting stock options, we determined that the price on the actual measurement date for a number of our stock option grants from 1997 through 2005 and into 2006 did not correspond to the price on the stated grant date and that certain option grants were retroactively priced. The investigation was conducted with the help of a law firm that was not previously involved with our stock option plans and procedures. The Committee completed the investigation on November 16, 2006. Based on the Committees recommendations, the Board of Directors took specific actions as a result thereof. The SEC commenced an inquiry upon notification by us of the initiation of our investigation. We have provided the results of our internal review and independent investigation to the SEC, and we have responded to requests from the SEC for documents and additional information. In March 2007, the SEC issued a formal order directing a private investigation. We intend to fully cooperate with the SEC. We are unable to predict the outcome of or the future costs related to the ongoing inquiry. |
20
Litigation | ||
We are party to lawsuits, arbitrations and other proceedings that arise in the normal course of our business. Many such lawsuits, arbitrations and other proceedings involve claims under policies that we underwrite as an insurer or reinsurer, the liabilities for which, we believe, have been adequately included in our loss reserves. Also, from time to time, we are a party to lawsuits, arbitrations and other proceedings that relate to disputes over contractual relationships with third parties, or that involve alleged errors and omissions on the part of our subsidiaries. We have provided accruals for these items to the extent we deem the losses probable and reasonably estimable. Although the ultimate outcome of these matters cannot be determined at this time, based on present information, the availability of insurance coverage and advice received from our outside legal counsel, we believe the resolution of these matters will not have a material adverse effect on our consolidated financial position, results of operations or cash flows. | ||
In addition to the litigation discussed above, the following lawsuits related to our 2006 stock option matter have been filed: | ||
Civil Action No. 07-456 (Consolidated); Bacas and Halgren, derivatively on behalf of HCC Insurance Holdings, Inc. v. Way et al.; In the United States District Court for the Southern District of Texas, Houston Division. This action consolidates all pending derivative suits into one action (Bacas suits). The Bacas action was filed on February 1, 2007, and the Halgren action was filed on February 28, 2007. We are named as a nominal defendant in this putative derivative action. The action purports to assert claims on behalf of us against several current and former officers and directors alleging improper manipulation of grant dates for option grants from 1995 through 2006, and includes causes of action for an accounting, breach of fiduciary duty, aiding and abetting breach of fiduciary duty, abuse of control, gross mismanagement, constructive fraud, corporate waste, unjust enrichment and rescission, as well as a claim under Sections 10(b), 14(a) and 20(a) of the Securities Exchange Act. Plaintiffs seek on our behalf, damages, punitive damages, disgorgement, restitution, rescission, an accounting, imposition of a constructive trust and changes in our corporate governance and internal controls. Plaintiffs also seek to recover their attorneys fees and costs from us for prosecuting the derivative claims. We have not yet responded to the complaint; however, our motion to stay the proceedings is pending a decision by the court. | ||
Civil Action No. 07-1084; Intermountain Ironworkers Trust Fund, derivatively and on behalf of HCC Insurance Holdings, Inc. v. Way et al.; In the United States District Court for the Southern District of Texas, Houston Division. The action was filed on March 30, 2007. We are named as a nominal defendant in this putative derivative action. The complaint asserts similar factual allegations and legal claims as asserted in the Bacas suits and seeks similar relief and remedies as sought in that action. On April 11, 2007, the Intermountain Ironworkers Trust Fund filed a motion seeking to consolidate this action with the Bacas action. On May 9, 2007, after the action was consolidated with Bacas, this claimant voluntarily withdrew from the suit. | ||
Civil Action No. 07-0801; In re HCC Insurance Holdings, Inc. Securities Litigation; In the United States District Court for the Southern District of Texas, Houston Division (formerly referred to as Bristol County Retirement System, individually and on behalf of all others similarly situated v. HCC Insurance Holdings, Inc. et al.). This action was filed on March 8, 2007. We are named as a defendant in this putative class action along with certain current and former officers and directors. In their amended complaint, plaintiffs seek to represent a class of persons who purchased or otherwise acquired our securities between May 3, 2005 and November 17, 2006, inclusive. The amended complaint purports to assert claims arising out of improper manipulation of option grant dates, alleging violation of Sections 20(a) and 10(b) of the Securities Exchange Act, as well as Rule 10b-5 promulgated thereunder. Plaintiff seeks recovery of compensatory damages for the putative class and costs and expenses. Our response to the amended complaint is due September 7, 2007. |
21
Indemnifications | ||
In conjunction with the sales of business assets and subsidiaries, we have provided indemnifications to the buyers. Certain indemnifications cover typical representations and warranties related to our responsibilities to perform under the sales contracts. Other indemnifications agree to reimburse the buyers for taxes or ERISA-related amounts, if any, assessed after the sale date but related to pre-sale activities. We cannot quantify the maximum potential exposure covered by all of our indemnifications because the indemnifications cover a variety of matters, operations and scenarios. Certain of these indemnifications have no time limit. For those with a time limit, the longest indemnification expires on December 31, 2009. | ||
We accrue a loss related to our indemnifications when a valid claim is made by a buyer and we believe we have potential exposure. We currently have several claims under indemnifications that cover certain net losses alleged to have been incurred in periods prior to our sale of certain subsidiaries or otherwise alleged to be covered under indemnification agreements related to such sales. As of June 30, 2007, we have recorded a liability of $16.6 million and have provided $5.2 million of letters of credit to cover our obligations or anticipated payments under these indemnifications. | ||
Pursuant to our by-laws, Delaware Corporate law and certain contractual agreements, we are required to advance attorneys fees and other expenses and may be required to indemnify our current and former directors and officers for liabilities arising from any action, suit or proceeding brought because the individual was acting as an officer or director of our company. Under certain limited circumstances, the individual may be required to reimburse us for any advances or indemnification payments made by us. In addition, we maintain directors and officers liability insurance, which may cover certain of these costs. We expense payments as advanced and recognize offsets if cash reimbursement is expected or received. In 2006 and 2007, we paid $2.1 million of attorneys fees incurred by current and former directors and officers who claimed the right to indemnity in conjunction with our 2006 stock option matter. It is not possible to determine the maximum potential impact on our consolidated net earnings, since our by-laws, Delaware law and our contractual agreements do not limit any such advances or indemnification payments. |
22
Effective date | ||||
Company | Segment | acquired | ||
Health Products Division of Allianz
Life Insurance Company
|
Insurance Company | October 2, 2006 | ||
G.B. Kenrick & Associates, Inc.
|
Agency | July 1, 2006 | ||
Novia Underwriters, Inc.
|
Agency | June 30, 2006 |
23
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
Net earned premium |
83.3 | % | 81.7 | % | 83.2 | % | 81.8 | % | ||||||||
Fee and commission income |
5.3 | 6.8 | 5.2 | 6.9 | ||||||||||||
Net investment income |
8.2 | 7.6 | 8.2 | 7.3 | ||||||||||||
Net realized investment loss |
(0.1 | ) | (0.2 | ) | | (0.1 | ) | |||||||||
Other operating income |
3.3 | 4.1 | 3.4 | 4.1 | ||||||||||||
Total revenue |
100.0 | 100.0 | 100.0 | 100.0 | ||||||||||||
Loss and loss adjustment expense, net |
50.7 | 47.2 | 51.0 | 46.8 | ||||||||||||
Policy acquisition costs, net |
14.6 | 15.9 | 14.4 | 15.5 | ||||||||||||
Other operating expense |
9.3 | 10.1 | 9.0 | 10.1 | ||||||||||||
Interest expense |
0.4 | 0.5 | 0.2 | 0.5 | ||||||||||||
Earnings before income tax expense |
25.0 | 26.3 | 25.4 | 27.1 | ||||||||||||
Income tax expense |
8.4 | 8.8 | 8.4 | 9.0 | ||||||||||||
Net earnings |
16.6 | % | 17.5 | % | 17.0 | % | 18.1 | % | ||||||||
Total revenue increased 24% to $1.2 billion in 2007, driven by significant growth in net earned premium and investment income. Approximately 60% of the increase in revenue in 2007 was due to the businesses acquired in 2006. | ||||||||||||||||
Gross written premium, net written premium and net earned premium are detailed below. Premium increased from organic growth in certain products and from acquisitions. Increased retentions also contributed to the growth in net written and earned premiums. See the Insurance Company Segment section below for further discussion of the relationship and changes in premium revenue. | ||||||||||||||||
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
Gross written premium |
$ | 1,264,702 | $ | 1,092,112 | $ | 665,601 | $ | 586,054 | ||||||||
Net written premium |
1,030,785 | 876,533 | 533,820 | 483,482 | ||||||||||||
Net earned premium |
991,986 | 783,891 | 494,386 | 403,320 | ||||||||||||
Fee and commission income declined slightly in 2007. The table below shows the source of our fee and commission income. | ||||||||||||||||
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
Agency |
$ | 45,133 | $ | 45,931 | $ | 21,777 | $ | 22,870 | ||||||||
Insurance companies |
18,128 | 19,616 | 9,359 | 11,008 | ||||||||||||
Fee and commission income |
$ | 63,261 | $ | 65,547 | $ | 31,136 | $ | 33,878 | ||||||||
24
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
Fixed income securities |
$ | 70,396 | $ | 51,491 | $ | 36,389 | $ | 27,186 | ||||||||
Short-term investments |
18,022 | 14,025 | 8,349 | 6,485 | ||||||||||||
Other investments |
12,569 | 10,252 | 5,049 | 3,840 | ||||||||||||
Total investment income |
100,987 | 75,768 | 49,787 | 37,511 | ||||||||||||
Investment expense |
(2,823 | ) | (3,014 | ) | (1,090 | ) | (1,338 | ) | ||||||||
Net investment income |
$ | 98,164 | $ | 72,754 | $ | 48,697 | $ | 36,173 | ||||||||
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
Average yield |
4.5 | % | 4.1 | % | 4.3 | % | 4.1 | % | ||||||||
Average tax equivalent yield |
5.3 | % | 5.0 | % | 5.1 | % | 5.0 | % | ||||||||
Weighted average maturity |
7.0 years | 8.0 years | ||||||||||||||
Weighted average duration |
4.9 years | 4.9 years |
25
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
Strategic investments |
$ | 23,237 | $ | 12,749 | $ | 11,578 | $ | 544 | ||||||||
Trading securities |
8,274 | 21,854 | 6,093 | 17,168 | ||||||||||||
Financial instruments |
2,693 | 1,992 | 1,506 | 1,169 | ||||||||||||
Other |
4,481 | 2,200 | 923 | 1,164 | ||||||||||||
Other operating income |
$ | 38,685 | $ | 38,795 | $ | 20,100 | $ | 20,045 | ||||||||
26
Gross | Net | NWP as | Net | |||||||||||||
written | written | % of | earned | |||||||||||||
premium | premium | GWP | premium | |||||||||||||
Six
months ended June 30, 2007 |
||||||||||||||||
Diversified financial products |
$ | 472,402 | $ | 379,715 | 80 | % | $ | 385,851 | ||||||||
Group life, accident and health |
405,174 | 383,948 | 95 | 384,640 | ||||||||||||
Aviation |
106,093 | 77,843 | 73 | 77,091 | ||||||||||||
London market account |
149,222 | 93,969 | 63 | 64,499 | ||||||||||||
Other specialty lines |
132,276 | 95,741 | 72 | 80,335 | ||||||||||||
Discontinued lines |
(465 | ) | (431 | ) | nm | (430 | ) | |||||||||
Totals |
$ | 1,264,702 | $ | 1,030,785 | 82 | % | $ | 991,986 | ||||||||
Six months ended June 30, 2006 |
||||||||||||||||
Diversified financial products |
$ | 450,733 | $ | 373,765 | 83 | % | $ | 348,319 | ||||||||
Group life, accident and health |
272,758 | 258,888 | 95 | 256,023 | ||||||||||||
Aviation |
115,096 | 90,364 | 79 | 72,231 | ||||||||||||
London market account |
158,165 | 90,517 | 57 | 48,865 | ||||||||||||
Other specialty lines |
95,123 | 63,093 | 66 | 58,536 | ||||||||||||
Discontinued lines |
237 | (94 | ) | nm | (83 | ) | ||||||||||
Totals |
$ | 1,092,112 | $ | 876,533 | 80 | % | $ | 783,891 | ||||||||
Three months ended June 30, 2007 |
||||||||||||||||
Diversified financial products |
$ | 260,149 | $ | 207,923 | 80 | $ | 193,337 | |||||||||
Group life, accident and health |
202,268 | 191,522 | 95 | 192,224 | ||||||||||||
Aviation |
54,430 | 38,240 | 70 | 37,747 | ||||||||||||
London market account |
81,087 | 48,837 | 60 | 30,603 | ||||||||||||
Other specialty lines |
67,781 | 47,420 | 70 | 40,597 | ||||||||||||
Discontinued lines |
(114 | ) | (122 | ) | nm | (122 | ) | |||||||||
Totals |
$ | 665,601 | $ | 533,820 | 80 | % | $ | 494,386 | ||||||||
Three months ended June 30, 2006 |
||||||||||||||||
Diversified financial products |
$ | 253,487 | $ | 212,120 | 84 | % | $ | 179,207 | ||||||||
Group life, accident and health |
138,604 | 129,445 | 93 | 128,262 | ||||||||||||
Aviation |
58,862 | 54,939 | 93 | 39,034 | ||||||||||||
London market account |
83,658 | 51,794 | 62 | 26,937 | ||||||||||||
Other specialty lines |
51,234 | 35,193 | 69 | 29,896 | ||||||||||||
Discontinued lines |
209 | (9 | ) | nm | (16 | ) | ||||||||||
Totals |
$ | 586,054 | $ | 483,482 | 82 | % | $ | 403,320 | ||||||||
nm Not meaningful comparison |
27
| Diversified financial products The growth in our gross written premium in 2007 resulted principally from organic growth in our surety and credit businesses, where pricing is stable and competition is reasonable. Gross written premium declined slightly in our directors and officers liability business, as we chose to write less business in foreign markets due to strong pricing competition. Premium volume in our other major products was stable, although pricing for these products is down slightly. The growth in net written and net earned premium was due to increased gross written premium. | ||
| Group life, accident and health Gross written, net written and net earned premium of our medical stop-loss product increased $129.9 million in 2007 from the acquisition of the Health Products Division. We retain all of our medical stop-loss business because the business is non-volatile and has very little catastrophe exposure. Profit margins remain at acceptable levels despite competition from the fully insured market. | ||
| Aviation Our domestic aviation business is stable, while gross written premium of our international business has declined. We have exercised underwriting discipline and written less international business due to competition and the resultant pressure on pricing. However, margins on decreased premium volume are still acceptable. Net written premium increased $11.3 million in the second quarter of 2006 due to a portfolio transfer of in-force premium to a new reinsurance program with a higher retention and decreased $2.5 million in the second quarter of 2007 due to a portfolio transfer with a lower retention. | ||
| London market account Gross written premium decreased slightly in 2007, as we wrote less energy and property business in a more competitive market. Premium rates are down. We reduced our aggregate property exposure in Florida and other hurricane-exposed onshore areas in 2006 and we are maintaining the reduced exposure in 2007. Additionally, due to the tightening of policy terms and conditions, our energy catastrophe exposure was significantly reduced in 2006, even though our business increased, and continues as such in 2007. Net written premium and net earned premium increased due to higher retentions. | ||
| Other specialty lines We experienced growth in our other specialty lines of business from increased writings in several products and from an acquisition. Net written premium and net earned premium increased due to higher gross written premium and retentions. Rates in this line have been relatively stable. |
28
Six months ended June 30, | Three months ended June 30, | |||||||||||||||||||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||||||||||||||||||
Net | Net | Net | Net | Net | Net | Net | Net | |||||||||||||||||||||||||
earned | loss | earned | loss | earned | loss | earned | loss | |||||||||||||||||||||||||
premium | ratio | premium | ratio | premium | ratio | premium | ratio | |||||||||||||||||||||||||
Diversified
financial products |
$ | 385,851 | 43.0 | % | $ | 348,319 | 50.4 | % | $ | 193,337 | 40.4 | % | $ | 179,207 | 50.0 | % | ||||||||||||||||
Group life, accident
and health |
384,640 | 76.9 | 256,023 | 70.1 | 192,224 | 78.3 | 128,262 | 70.5 | ||||||||||||||||||||||||
Aviation |
77,091 | 54.5 | 72,231 | 56.4 | 37,747 | 59.1 | 39,034 | 58.1 | ||||||||||||||||||||||||
London market account |
64,499 | 63.7 | 48,865 | 45.5 | 30,603 | 70.8 | 26,937 | 43.4 | ||||||||||||||||||||||||
Other specialty lines |
80,335 | 69.4 | 58,536 | 59.6 | 40,597 | 69.0 | 29,896 | 55.5 | ||||||||||||||||||||||||
Discontinued lines |
(430 | ) | nm | (83 | ) | nm | (122 | ) | nm | (16 | ) | nm | ||||||||||||||||||||
Totals |
$ | 991,986 | 60.9 | % | $ | 783,891 | 57.8 | % | $ | 494,386 | 61.3 | % | $ | 403,320 | 57.3 | % | ||||||||||||||||
Expense ratio |
23.1 | 26.4 | 22.6 | 25.7 | ||||||||||||||||||||||||||||
Combined ratio |
84.0 | % | 84.2 | % | 83.9 | % | 83.0 | % | ||||||||||||||||||||||||
nm Not meaningful comparison |
| Diversified financial products The decrease in the loss ratio was due to better underwriting results for certain business written in 2006 and earned in 2007, compared to business written in 2005 and earned in 2006, and positive loss development on our international professional indemnity and D&O lines of business. Additionally, our surety and credit businesses, which have lower loss ratios than other businesses in this line, are growing and reducing the overall loss ratio. | ||
| Group life, accident and health The net loss ratio was higher on business acquired in the Health Products Division acquisition. Over time, as the acquired business is re-underwritten, we expect its loss ratio will decline to the level of our existing medical stop-loss business. The net loss ratio was also higher due to higher than expected claims and more of our business being written on a net of commission basis. While the net business increased our loss ratio (since the denominator is lower), it reduced our expense ratio such that our combined ratio and margin for this business remained stable. | ||
| London market account The higher loss ratio was principally due to negative development in our London accident and health and energy lines of business due to higher than expected claims. | ||
| Other specialty lines The increase relates to losses in our marine and UK liability lines of business. |
29
Six months ended June 30, | Three months ended June 30, | |||||||||||||||
2007 | 2006 | 2007 | 2006 | |||||||||||||
Net earnings |
$ | 197,862 | $ | 168,286 | $ | 101,172 | $ | 89,144 | ||||||||
Change in premium, claims and other
receivables, net of reinsurance, other
payables and restricted cash |
(12,932 | ) | (50,226 | ) | (5,086 | ) | (37,213 | ) | ||||||||
Change in unearned premium, net |
41,633 | 104,214 | 42,365 | 86,062 | ||||||||||||
Change in loss and loss adjustment
expense payable, net of reinsurance
recoverables |
200,558 | 113,416 | 72,846 | 77,009 | ||||||||||||
Change in trading portfolio |
4,865 | (84,491 | ) | (6,093 | ) | (36,497 | ) | |||||||||
Other, net |
(31,686 | ) | 8,742 | (35,215 | ) | 3,345 | ||||||||||
Cash provided by operating activities |
$ | 400,300 | $ | 259,941 | $ | 169,989 | $ | 181,850 | ||||||||
30
31
32
33
34
a. | Election of Directors | |
The following persons were elected to serve on the Board of Directors until the 2008 Annual Meeting of Shareholders or until their successors have been duly elected and qualified. The Directors received the votes next to their respective names. |
Name | For | Votes Withheld | ||||||
Frank J. Bramanti |
96,958,470 | 5,649,457 | ||||||
Patrick B. Collins |
91,034,717 | 11,573,210 | ||||||
James R. Crane |
89,854,255 | 12,753,672 | ||||||
J. Robert Dickerson |
88,548,478 | 14,059,449 | ||||||
Walter M. Duer |
91,901,636 | 10,706,291 | ||||||
Edward H. Ellis, Jr. |
92,332,256 | 10,275,671 | ||||||
James C. Flagg, Ph.D. |
90,348,720 | 12,259,207 | ||||||
Allan W. Fulkerson |
97,836,381 | 4,771,546 | ||||||
John N. Molbeck, Jr. |
95,930,280 | 6,677,647 | ||||||
Michael A. F. Roberts |
88,759,383 | 13,848,544 |
b. | Adoption of the 2007 Incentive Compensation Plan | |
Shareholders were requested to approve the adoption of the 2007 Incentive Compensation Plan. The Plan was approved by the shareholders, who voted as follows: 87,848,840 shares in favor, 3,892,967 against, 325,635 abstained, and 10,540,486 broker non-votes. | ||
c. | Ratification of PricewaterhouseCoopers LLP | |
Shareholders were requested to ratify the appointment of PricewaterhouseCoopers LLP, as our independent registered public accounting firm for the year ended December 31, 2007. Such appointment was approved by the shareholders, who voted as follows: 98,525,041shares in favor, 4,063,875 against, and 19,009 abstained. | ||
d. | Vote on Shareholder Proposal | |
Shareholders were requested to vote on a shareholder proposal requesting that management implement equal employment opportunity policies regarding sexual orientation. The proposal was rejected by the shareholders, who voted as follows: 43,491,825 shares in favor, 39,775,764 against, 8,799,851 abstained, and 10,540,488 broker non-votes. For the proposal to pass under Delaware law, the shares in favor must exceed 50% of the total shares present at the meeting, in person or by proxy, and entitled to vote (102,607,928, in this case). |
35
31.1 | Certification by Chief Executive Officer | |
31.2 | Certification by Chief Financial Officer | |
32.1 | Certification with Respect to Quarterly Report |
HCC Insurance Holdings, Inc. | ||||
(Registrant) | ||||
August 9,
2007
|
/s/ Frank J. Bramanti | |||
(Date)
|
Frank J. Bramanti, Chief Executive Officer | |||
August 9,
2007
|
/s/ Edward H. Ellis, Jr. | |||
(Date)
|
Edward H. Ellis, Jr., Executive Vice President | |||
and Chief Financial Officer |
36